WHO ICTRP trial
Anti-oxidant effect of Caffeine-Q10 supplementation
IRCT201206204663N10 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201206204663N10 |
|---|---|
| Public title | Anti-oxidant effect of Caffeine-Q10 supplementation |
| Scientific title | Effect of two-week High-impact Aerobic training and caffeine plus Ubiquinone supplementation on serum total anti-oxidant capacity and malondialdehyde in female athletes following once-session exhaustive training |
| Primary sponsor | University of Tabriz |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Exercise-induced physiological stress. Drug or medicament, unspecified;Y93? Z71.3;Drug or medicament, unspecified |
| Interventions | Intervention 1: The subjects in placebo group will intake 11 mg/kg/day maltodexterine for 2 weeks (11 sessions). Intervention 2: The subjects in Ubiquinone group will intake 5 mg/kg/day Ubiquinone plus 6 mg/kg/day maltodexterine for 2 weeks… |
| Registration date | Jul 3, 2013 |
| Target size | 32 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: